MedPath
FDA Approval

Ceftazidime

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
WG Critical Care, LLC
DUNS: 829274633
Effective Date
September 23, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ceftazidime(6 g in 100 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ceftazidime

Product Details

NDC Product Code
44567-237
Application Number
ANDA062640
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
September 1, 2021
Code: 9M416Z9QNRClass: ACTIMQuantity: 6 g in 100 mL
natural latex rubberInactive
Code: 2LQ0UUW8INClass: CNTMQuantity: 0 1 in 100 mL
© Copyright 2025. All Rights Reserved by MedPath